AVIR (STOCKS)
Atea Pharmaceuticals, Inc. Common Stock
$5.710000
+0.040000 (+0.71%)
Prev close: $5.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jean-Pierre Sommadossi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $454.93M
- Employees
- 56
- P/E (TTM)
- -2.92
- P/B (TTM)
- 1.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.57 | $-0.54 | -0.0294 | -5.44% |
|
Sep 2025 (Q3)
|
$-0.53 | $-0.45 | -0.0812 | -18.09% |
|
Jun 2025 (Q2)
|
$-0.44 | $-0.42 | -0.0167 | -3.95% |
|
Mar 2025 (Q1)
|
$-0.40 | $-0.42 | +0.0182 | +4.35% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $180.89M |
| Depreciation and Amortization | $416.00K |
| Research and Development | $148.02M |
| Other Operating Expenses | $32.45M |
| Operating Income/Loss | -$180.89M |
| Income/Loss From Continuing Operations After Tax | -$158.35M |
| Income/Loss From Continuing Operations Before Tax | -$164.51M |
| Income Tax Expense/Benefit | -$6.16M |
| Income Tax Expense/Benefit, Deferred | -$6.36M |
| Net Income/Loss | -$158.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$158.35M |
| Net Income/Loss Available To Common Stockholders, Basic | -$158.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.94 |
| Diluted Earnings Per Share | -$1.94 |
| Basic Average Shares | 81,495,352 |
| Diluted Average Shares | 81,495,352 |
| Assets | $315.22M |
| Current Assets | $310.99M |
| Cash | $301.83M |
| Other Current Assets | $9.16M |
| Noncurrent Assets | $4.23M |
| Fixed Assets | $457.00K |
| Other Non-current Assets | $3.77M |
| Liabilities | $39.78M |
| Current Liabilities | $39.78M |
| Accounts Payable | $12.95M |
| Wages | $6.44M |
| Other Current Liabilities | $20.40M |
| Noncurrent Liabilities | $0.00 |
| Equity | $275.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $275.43M |
| Liabilities And Equity | $315.22M |
| Net Cash Flow From Operating Activities | -$132.03M |
| Net Cash Flow From Operating Activities, Continuing | -$132.03M |
| Net Cash Flow From Investing Activities | $188.79M |
| Net Cash Flow From Investing Activities, Continuing | $188.79M |
| Net Cash Flow From Financing Activities | -$25.75M |
| Net Cash Flow From Financing Activities, Continuing | -$25.75M |
| Net Cash Flow | $31.02M |
| Net Cash Flow, Continuing | $31.02M |
| Comprehensive Income/Loss | -$158.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$158.41M |
| Other Comprehensive Income/Loss | -$59.00K |